MicroRNA and messenger RNA profiling reveals new biomarkers and mechanisms for RDX induced neurotoxicity

BMC Genomics

Volumn 15, Issue , 2014, Pages

  Deng, Youping ^a,b   Ai, Junmei ^b   Guan, Xin ^c   Wang, Zhaohui ^a,h   Yan, Bin ^d,e   Zhang, Daqin ^f   Liu, Chang ^a   Wilbanks, Mitch S ^g   Escalon, Barbara Lynn ^h   Meyers, Sharon A ^a   Yang, Mary Qu ^i,j   Perkins, Edward J ^f  

^a WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c Bristol Bay Native Corporation   (United States)

^d HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f SOOCHOW UNIVERSITY   (China)

^g US ARMY ENGINEER RESEARCH AND DEVELOPMENT CENTER   (United States)

^h UNIVERSITY OF LOUISIANA AT MONROE   (United States)

ⁱ Wuhan University of Science and Technology ^*  (United States)

^j UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BTG3 ASSOCIATED NUCLEAR PROTEIN; CALDESMON; CALDESMON 1; CENTROSOMAL PROTEIN 350; CHROMOSOME 5 OPEN READING FRAME 13; CYCLONITE; FAMILY WITH SEQUENCE SIMILARITY 82 MEMBER A2; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; KIAA1033 PROTEIN; LIPOPOLYSACCHARIDE INDUCED TUMOR NECROSIS FACTOR; MEMBRANE PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 129; MICRORNA 135A; MICRORNA 27A; MICRORNA 27B; MICRORNA 320; MICRORNA 342 3P; MICRORNA 674 5P; MICRORNA 71; MICRORNA 7A; MICRORNA 98; NEURONAL PENTRAXIN II; PENTRAXIN; SOLUTE CARRIER FAMILY 38 MEMBER 2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VGF NERVE GROWTH FACTOR INDUCIBLE; POLLUTANT; TRIAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; INFLAMMATION; NEUROTOXICITY; NONHUMAN; PROTEIN ANALYSIS; RAT; RNA ANALYSIS; UPREGULATION; ANIMAL; BIOLOGY; BRAIN; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; POLLUTANT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TOXICITY; TOXICITY AND INTOXICATION;

ANIMALS; BIOMARKERS; BRAIN; COMPUTATIONAL BIOLOGY; ENVIRONMENTAL POLLUTANTS; FEMALE; GENE EXPRESSION PROFILING; INFLAMMATION; MICRORNAS; NEUROTOXICITY SYNDROMES; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRIAZINES;

EID: 84964315274     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-S11-S1     Document Type: Article

References (43)

1. Goldberg DJ, Green ST, Nathwani D, McMenamin J, Hamlet N, Kennedy DH: RDX intoxication causing seizures and a widespread petechial rash mimicking meningococcaemia. J R Soc Med 1992, 85:181.
2. Johnson MS, Quinn MJ, Bazar MA, Gust KA, Escalon BL, Perkins EJ: Subacute toxicity of oral 2, 6-dinitrotoluene and 1, 3, 5-trinitro-1, 3, 5-triazine (RDX) exposure to the northern bobwhite (Colinus virginianus). Environ Toxicol Chem 2007, 26:1481-1487.
3. Quinn MJ, Bazar MA, McFarland CA, Perkins EJ, Gust KA, Johnson MS: Sublethal effects of subacute exposure to RDX (1, 3, 5-trinitro-1, 3, 5-triazine) in the northern bobwhite (Colinus virginianus). Environ Toxicol Chem 2009, 28:1266-1270.
4. Talmage SS, Opresko DM, Maxwell CJ, Welsh CJ, Cretella FM, Reno PH, Daniel FB: Nitroaromatic munition compounds: environmental effects and screening values. Rev Environ Contam Toxicol 1999, 161:1-156.
5. Burdette LJ, Cook LL, Dyer RS: Convulsant properties of cyclotrimethylenetrinitramine (RDX): spontaneous audiogenic, and amygdaloid kindled seizure activity. Toxicol Appl Pharmacol 1988, 92:436-444.
6. Pan X, San Francisco MJ, Lee C, Ochoa KM, Xu X, Liu J, Zhang B, Cox SB, Cobb GP: Examination of the mutagenicity of RDX and its N-nitroso metabolites using the Salmonella reverse mutation assay. Mutat Res 2007, 629:64-69.
7. Testud F, Glanclaude JM, Descotes J: Acute hexogen poisoning after occupational exposure. J Toxicol Clin Toxicol 1996, 34:109-111.
8. Williams LR, Aroniadou-Anderjaska V, Qashu F, Finne H, Pidoplichko V, Bannon DI, Braga MF: RDX binds to the GABA(A) receptor-convulsant site and blocks GABA(A) receptor-mediated currents in the amygdala: a mechanism for RDX-induced seizures. Environ Health Perspect 2011, 119:357-363.
9. Williams LR, Wong K, Stewart A, Suciu C, Gaikwad S, Wu N, Dileo J, Grossman L, Cachat J, Hart P, et al: Behavioral and physiological effects of RDX on adult zebrafish. Comp Biochem Physiol C Toxicol Pharmacol 2012, 155:33-38.
10. Garcia-Reyero N, Habib T, Pirooznia M, Gust KA, Gong P, Warner C, Wilbanks M, Perkins E: Conserved toxic responses across divergent phylogenetic lineages: a meta-analysis of the neurotoxic effects of RDX among multiple species using toxicogenomics. Ecotoxicology 2011, 20:580-594.
11. Zhang B, Pan X: RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ Health Perspect 2009, 117:231-240.
12. Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA: A miRNA signature of prion induced neurodegeneration. PLoS One 2008, 3:e3652.
13. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
14. Karres JS, Hilgers V, Carrera I, Treisman J, Cohen SM: The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila. Cell 2007, 131:136-145.
15. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K: MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007, 131:146-159.
16. Leung AK, Sharp PA: microRNAs: a safeguard against turmoil? Cell 2007, 130:581-585.
17. Vasudevan S, Tong Y, Steitz JA: Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934.
18. National Research Council: Guide for the care and use of laboratory animals National Academy Press, Washington D.C; 1996.
19. Perkins EJ, Bao W, Guan X, Ang CY, Wolfinger RD, Chu TM, Meyer SA, Inouye LS: Comparison of transcriptional responses in liver tissue and primary hepatocyte cell cultures after exposure to hexahydro-1, 3, 5-trinitro-1, 3, 5-triazine. BMC Bioinformatics 2006, 7(Suppl 4):S22.
20. Deng Y, Meyer SA, Guan X, Escalon BL, Ai J, Wilbanks MS, Welti R, Garcia-Reyero N, Perkins EJ: Analysis of common and specific mechanisms of liver function affected by nitrotoluene compounds. PLoS One 2011, 6: e14662.
21. Deng Y, Johnson DR, Guan X, Ang CY, Ai J, Perkins EJ: In vitro gene regulatory networks predict in vivo function of liver. BMC Syst Biol 2010, 4:153.
22. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006, 34:D140-D144.
23. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB: Prediction of mammalian microRNA targets. Cell 2003, 115:787-798.
24. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, Macmenamin P, da P, Gunsalus KC, Stoffel M, et al: Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500.
25. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, Sikic BI: Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res 2005, 65:8679-8689.
26. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, et al: microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 2008, 68:3566-3572.
27. Junn E, Lee KW, Jeong BS, Chan TW, Im JY, Mouradian MM: Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci USA 2009, 106:13052-13057.
28. Abu-Elneel K, Liu T, Gazzaniga FS, Nishimura Y, Wall DP, Geschwind DH, Lao K, Kosik KS: Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 2008, 9:153-161.
29. Zhao Y, Lu S, Wu L, Chai G, Wang H, Chen Y, Sun J, Yu Y, Zhou W, Zheng Q, et al: Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol Cell Biol 2006, 26:2782-2790.
30. Montag J, Hitt R, Opitz L, Schulz-Schaeffer WJ, Hunsmann G, Motzkus D: Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease. Mol Neurodegener 2009, 4:36.
31. Govek EE, Newey SE, Van Aelst L: The role of the Rho GTPases in neuronal development. Genes Dev 2005, 19:1-49.
32. Uchida Y, Ohshima T, Sasaki Y, Suzuki H, Yanai S, Yamashita N, Nakamura F, Takei K, Ihara Y, Mikoshiba K, et al: Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells 2005, 10:165-179.
33. Garbe DS, Bashaw GJ: Axon guidance at the midline: from mutants to mechanisms. Crit Rev Biochem Mol Biol 2004, 39:319-341.
34. Gianakopoulos PJ, Skerjanc IS: Hedgehog signaling induces cardiomyogenesis in P19 cells. J Biol Chem 2005, 280:21022-21028.
35. Charron F, Tessier-Lavigne M: Novel brain wiring functions for classical morphogens: a role as graded positional cues in axon guidance. Development 2005, 132:2251-2262.
36. Chen Y, Beffert U, Ertunc M, Tang TS, Kavalali ET, Bezprozvanny I, Herz J: Reelin modulates NMDA receptor activity in cortical neurons. J Neurosci 2005, 25:8209-8216.
37. Yip YP, Kronstadt-O'Brien P, Capriotti C, Cooper JA, Yip JW: Migration of sympathetic preganglionic neurons in the spinal cord is regulated by Reelin-dependent Dab1 tyrosine phosphorylation and CrkL. J Comp Neurol 2007, 502:635-643.
38. Akopians AL, Babayan AH, Beffert U, Herz J, Basbaum AI, Phelps PE: Contribution of the Reelin signaling pathways to nociceptive processing. Eur J Neurosci 2008, 27:523-537.
39. Ai X, Kitazawa T, Do AT, Kusche-Gullberg M, Labosky PA, Emerson CP Jr: SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation. Development 2007, 134:3327-3338.
40. Fujitani M, Yamagishi S, Che YH, Hata K, Kubo T, Ino H, Tohyama M, Yamashita T: P311 accelerates nerve regeneration of the axotomized facial nerve. J Neurochem 2004, 91:737-744.
41. Katoh H, Aoki J, Ichikawa A, Negishi M: p160 RhoA-binding kinase ROKalpha induces neurite retraction. J Biol Chem 1998, 273:2489-2492.
42. Kilic E, Kilic U, Matter CM, Luscher TF, Bassetti CL, Hermann DM: Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase. Stroke 2005, 36:332-336.
43. Freitas RN, Khaw KT, Wu K, Bowman R, Jeffery H, Luben R, Wareham NJ, Rodwell S: HMGCR gene polymorphism is associated with stroke risk in the EPIC-Norfolk study. Eur J Cardiovasc Prev Rehabil 2010, 17:89-93.